Intellia Therapeutics’ Lonvo-z Wins FDA Priority Review for One-Time HAE Treatment

FDA sets Prescription Drug User Fee Act (PDUFA) date of March 10, 2027 Positions lonvo-z to be the world’s first in vivo CRISPR-based therapy an...

September 10, 2026 | Thursday | News
Aptar Pharma Partners with Aceso Therapeutics to Advance Inhaled ASO for Cystic Fibrosis

-Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, today announced a collaboration with Aceso Therapeutics, a...

September 09, 2026 | Wednesday | News
Making Earlier Cancer Detection a Reality Through Blood-Based Diagnostics

    Early detection remains one of the biggest challenges in cancer care, particularly for ovarian cancer, where symptoms can be difficult to r...

September 09, 2026 | Wednesday | Interaction
Mabwell Reports Positive Phase Ib/IIa Results for Anti-ST2 Antibody 9MW1911 in COPD

Mabwell, an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced the Phase Ib/IIa clinical results of its anti-S...

September 07, 2026 | Monday | News
Ono Pharma Partners With Aitia to Discover New Neurological Disease Targets Using Causal AI

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”) announced that it has entered into a drug ...

September 03, 2026 | Thursday | News
BioMed X Relocates Global Headquarters to Heidelberg Innovation Park, Partners With BioLabs

BioMed X, a leading innovation engine for pharma, announced the relocation of its global headquarters to LAB22 at Heidelberg Innovation Park (hip), toget...

September 03, 2026 | Thursday | News
SciSparc Advances SCI-210 Clinical Trial for Autism Symptoms as Enrollment Reaches 26 Children

SciSparc Ltd. (“Company” or “SciSparc”), announced that NeuroThera Labs Inc.  ("NeuroThera"), a clinical-stage pharmaceuti...

September 02, 2026 | Wednesday | News
Stryker to Acquire ZuriMED, Expanding Rotator Cuff Augmentation Portfolio

Stryker, a global leader in medical technologies, announced it has signed a definitive agreement to acquire ZuriMED, a privately held company and develop...

September 02, 2026 | Wednesday | News
Teva and Trump Administration Commit to Lowering Costs of Select Medicines for U.S. Medicaid Patients

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced a shared commitment with the Trump Administration to lower the cost...

September 02, 2026 | Wednesday | News
10x Genomics Wins $4.8 Million Patent Infringement Verdict Against Parse Biosciences

10x Genomics, Inc., the life science technology leader focused on accelerating science and advancing human health, announced that a jury in the U.S. Dist...

August 31, 2026 | Monday | News
Evonik Invests CAD 150 Million in New GMP Lipid-Based Drug Manufacturing Facility in Vancouver

Evonik is investing in a new GMP drug product manufacturing facility for lipid-based drug delivery in Vancouver, Canada. The facility will increase Evoni...

August 31, 2026 | Monday | News
Teva Bids to Acquire BioXcel’s Novel At-Home Neuroscience Treatment for Agitation

Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. announced it has made a bid to acquire an innovative neurosc...

August 31, 2026 | Monday | News
Revolution Medicines Wins FDA Approval for RASONQUE in Metastatic Pancreatic Cancer

Revolution Medicines, Inc., a global commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for patie...

August 28, 2026 | Friday | News
Globus Medical Acquires Higgs Boson Health to Advance Digital Healthcare and Surgical Intelligence

Globus Medical, Inc., a leading musculoskeletal technology company, announced the acquisition of Higgs Boson Health, a digital healthcare experience comp...

August 28, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close